SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001104659-24-082352
Filing Date
2024-07-24
Accepted
2024-07-24 16:30:53
Documents
5
Period of Report
2024-07-24

Document Format Files

Seq Description Document Type Size
1 PREM14A tm2419772-1_prem14a.htm PREM14A 2384002
2 EX-FILING FEES tm2419772d2_ex-filingfees.htm EX-FILING FEES 22735
3 GRAPHIC lg_alimera-4c.jpg GRAPHIC 17395
4 GRAPHIC px_24alimeraproxy01pg01-bw.jpg GRAPHIC 233792
5 GRAPHIC px_24alimeraproxy01pg02-bw.jpg GRAPHIC 171312
  Complete submission text file 0001104659-24-082352.txt   2928630
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-34703 | Film No.: 241138468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)